AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 184 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,079,000 | -47.7% | 85,000 | -57.5% | 3.31% | +23.4% |
| Q3 2017 | $9,720,000 | +94.7% | 200,000 | +110.5% | 2.68% | -5.0% |
| Q2 2017 | $4,992,000 | +29.5% | 95,000 | +11.8% | 2.82% | +48.0% |
| Q1 2017 | $3,855,000 | -11.4% | 85,000 | -26.1% | 1.91% | -26.7% |
| Q4 2016 | $4,353,000 | -65.0% | 115,000 | -65.2% | 2.60% | +17.2% |
| Q3 2016 | $12,454,000 | +371.7% | 330,000 | +120.0% | 2.22% | +106.7% |
| Q2 2016 | $2,640,000 | +189.5% | 150,000 | +100.0% | 1.07% | +221.6% |
| Q1 2016 | $912,000 | -14.4% | 75,000 | +25.0% | 0.33% | -20.3% |
| Q3 2015 | $1,065,000 | -71.7% | 60,015 | -50.0% | 0.42% | -73.5% |
| Q1 2015 | $3,761,000 | -14.1% | 120,000 | -20.0% | 1.58% | -25.2% |
| Q4 2014 | $4,379,000 | +11.4% | 150,000 | -21.1% | 2.12% | +0.8% |
| Q3 2014 | $3,931,000 | +8.9% | 190,000 | +30.4% | 2.10% | +24.8% |
| Q2 2014 | $3,609,000 | -18.9% | 145,700 | -30.6% | 1.68% | -18.2% |
| Q1 2014 | $4,450,000 | +120.2% | 210,000 | +86.7% | 2.06% | +78.6% |
| Q4 2013 | $2,021,000 | – | 112,500 | – | 1.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LEVIN CAPITAL STRATEGIES, L.P. | 1,373,542 | $15,658,000 | 1.56% |
| DAFNA Capital Management LLC | 289,040 | $3,295,000 | 0.87% |
| Integral Health Asset Management, LLC | 250,000 | $2,850,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 193,266 | $2,203,000 | 0.80% |
| PFM Health Sciences, LP | 2,182,684 | $24,883,000 | 0.73% |
| DCF Advisers, LLC | 136,501 | $1,556,000 | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,977,020 | $33,938,000 | 0.66% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $3,532,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 750,000 | $8,550,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,232,600 | $14,052,000 | 0.52% |